
### [MONDO:0021096](http://purl.obolibrary.org/obo/MONDO_0021096)
**Label:** papillary epithelial neoplasm

**Subclasses:** [MONDO:0000935](http://purl.obolibrary.org/obo/MONDO_0000935) (larynx squamous papilloma), [MONDO:0003929](http://purl.obolibrary.org/obo/MONDO_0003929) (micropapillomatosis labialis), [MONDO:0003925](http://purl.obolibrary.org/obo/MONDO_0003925) (ethmoid sinus inverted papilloma), [MONDO:0003923](http://purl.obolibrary.org/obo/MONDO_0003923) (ethmoid sinus Schneiderian papilloma), [MONDO:0016285](http://purl.obolibrary.org/obo/MONDO_0016285) (papillary carcinoma of the cervix uteri), [MONDO:0004457](http://purl.obolibrary.org/obo/MONDO_0004457) (maxillary sinus Schneiderian papilloma), [MONDO:0004056](http://purl.obolibrary.org/obo/MONDO_0004056) (bladder papillary urothelial carcinoma), [MONDO:0021078](http://purl.obolibrary.org/obo/MONDO_0021078) (glandular papilloma), [MONDO:0006353](http://purl.obolibrary.org/obo/MONDO_0006353) (paranasal sinus Schneiderian papilloma), [MONDO:0006350](http://purl.obolibrary.org/obo/MONDO_0006350) (papillary transitional cell carcinoma), [MONDO:0004292](http://purl.obolibrary.org/obo/MONDO_0004292) (supraglottis verrucous carcinoma), [MONDO:0004290](http://purl.obolibrary.org/obo/MONDO_0004290) (subglottis verrucous carcinoma), [MONDO:0021109](http://purl.obolibrary.org/obo/MONDO_0021109) (inverted urothelial papilloma), [MONDO:0017884](http://purl.obolibrary.org/obo/MONDO_0017884) (papillary renal cell carcinoma), [MONDO:0001635](http://purl.obolibrary.org/obo/MONDO_0001635) (bladder squamous papilloma), [MONDO:0004509](http://purl.obolibrary.org/obo/MONDO_0004509) (intrahepatic biliary papillomatosis), [MONDO:0003813](http://purl.obolibrary.org/obo/MONDO_0003813) (ovarian papillary tumor), [MONDO:0004506](http://purl.obolibrary.org/obo/MONDO_0004506) (microscopic breast papilloma), [MONDO:0004507](http://purl.obolibrary.org/obo/MONDO_0004507) (atypical breast papilloma), [MONDO:0004505](http://purl.obolibrary.org/obo/MONDO_0004505) (central breast papilloma), [MONDO:0003534](http://purl.obolibrary.org/obo/MONDO_0003534) (papillary thymic adenocarcinoma), [MONDO:0003776](http://purl.obolibrary.org/obo/MONDO_0003776) (renal pelvis inverted papilloma), [MONDO:0003777](http://purl.obolibrary.org/obo/MONDO_0003777) (renal pelvis urothelial papilloma), [MONDO:0003535](http://purl.obolibrary.org/obo/MONDO_0003535) (fallopian tube papillary adenocarcinoma), [MONDO:0003532](http://purl.obolibrary.org/obo/MONDO_0003532) (breast papillary carcinoma), [MONDO:0004226](http://purl.obolibrary.org/obo/MONDO_0004226) (diffuse intraductal papillomatosis), [MONDO:0006006](http://purl.obolibrary.org/obo/MONDO_0006006) (verrucous carcinoma), [MONDO:0016268](http://purl.obolibrary.org/obo/MONDO_0016268) (papillary carcinoma of the corpus uteri), [MONDO:0002537](http://purl.obolibrary.org/obo/MONDO_0002537) (inverted papilloma), [MONDO:0002534](http://purl.obolibrary.org/obo/MONDO_0002534) (fallopian tube papilloma), [MONDO:0002533](http://purl.obolibrary.org/obo/MONDO_0002533) (papillary adenoma), [MONDO:0002536](http://purl.obolibrary.org/obo/MONDO_0002536) (skin papilloma), [MONDO:0002535](http://purl.obolibrary.org/obo/MONDO_0002535) (verrucous papilloma), [MONDO:0004433](http://purl.obolibrary.org/obo/MONDO_0004433) (penis papillary carcinoma), [MONDO:0003064](http://purl.obolibrary.org/obo/MONDO_0003064) (inverted transitional papilloma), [MONDO:0001680](http://purl.obolibrary.org/obo/MONDO_0001680) (vaginal mullerian papilloma), [MONDO:0006190](http://purl.obolibrary.org/obo/MONDO_0006190) (endolymphatic sac tumor (disease)), [MONDO:0018955](http://purl.obolibrary.org/obo/MONDO_0018955) (recurrent respiratory papillomatosis), [MONDO:0006509](http://purl.obolibrary.org/obo/MONDO_0006509) (papillary carcinoma), [MONDO:0004326](http://purl.obolibrary.org/obo/MONDO_0004326) (sphenoid sinus inverted papilloma), [MONDO:0004327](http://purl.obolibrary.org/obo/MONDO_0004327) (sphenoid sinus Schneiderian papilloma), [MONDO:0004448](http://purl.obolibrary.org/obo/MONDO_0004448) (frontal sinus inverted papilloma), [MONDO:0003755](http://purl.obolibrary.org/obo/MONDO_0003755) (urinary tract non-invasive transitional cell neoplasm), [MONDO:0006228](http://purl.obolibrary.org/obo/MONDO_0006228) (gastric papillary adenocarcinoma), [MONDO:0003752](http://purl.obolibrary.org/obo/MONDO_0003752) (frontal sinus Schneiderian papilloma), [MONDO:0006349](http://purl.obolibrary.org/obo/MONDO_0006349) (papillary cystic neoplasm), [MONDO:0003873](http://purl.obolibrary.org/obo/MONDO_0003873) (ovarian surface papilloma), [MONDO:0003874](http://purl.obolibrary.org/obo/MONDO_0003874) (ovary papillary carcinoma), [MONDO:0003753](http://purl.obolibrary.org/obo/MONDO_0003753) (nasal vestibule squamous papilloma), [MONDO:0004204](http://purl.obolibrary.org/obo/MONDO_0004204) (squamous cell papilloma of skin), [MONDO:0004289](http://purl.obolibrary.org/obo/MONDO_0004289) (glottis verrucous carcinoma), [MONDO:0003872](http://purl.obolibrary.org/obo/MONDO_0003872) (ovarian papillary cystadenoma), [MONDO:0002388](http://purl.obolibrary.org/obo/MONDO_0002388) (intracystic papillary adenoma), [MONDO:0004043](http://purl.obolibrary.org/obo/MONDO_0004043) (ureter inverted papilloma), [MONDO:0004044](http://purl.obolibrary.org/obo/MONDO_0004044) (ureter urothelial papilloma), [MONDO:0004041](http://purl.obolibrary.org/obo/MONDO_0004041) (urothelial papilloma), [MONDO:0004042](http://purl.obolibrary.org/obo/MONDO_0004042) (urethra inverted papilloma), [MONDO:0004040](http://purl.obolibrary.org/obo/MONDO_0004040) (urinary bladder inverted papilloma), [MONDO:0002758](http://purl.obolibrary.org/obo/MONDO_0002758) (vulva verrucous carcinoma), [MONDO:0002518](http://purl.obolibrary.org/obo/MONDO_0002518) (gallbladder papillary neoplasm), [MONDO:0001825](http://purl.obolibrary.org/obo/MONDO_0001825) (squamous papilloma), [MONDO:0002759](http://purl.obolibrary.org/obo/MONDO_0002759) (bladder verrucous carcinoma), [MONDO:0002512](http://purl.obolibrary.org/obo/MONDO_0002512) (papillary adenocarcinoma), [MONDO:0009837](http://purl.obolibrary.org/obo/MONDO_0009837) (choroid plexus papilloma), [MONDO:0003442](http://purl.obolibrary.org/obo/MONDO_0003442) (bladder papillary urothelial neoplasm), [MONDO:0003443](http://purl.obolibrary.org/obo/MONDO_0003443) (papillary urothelial neoplasm), [MONDO:0004254](http://purl.obolibrary.org/obo/MONDO_0004254) (focal intraductal papillomatosis), [MONDO:0006278](http://purl.obolibrary.org/obo/MONDO_0006278) (lung papilloma), [MONDO:0021276](http://purl.obolibrary.org/obo/MONDO_0021276) (papilloma of buccal mucosa), [MONDO:0004131](http://purl.obolibrary.org/obo/MONDO_0004131) (anal Buschke-Lowenstein tumor), [MONDO:0021275](http://purl.obolibrary.org/obo/MONDO_0021275) (papilloma of eyelid), [MONDO:0004253](http://purl.obolibrary.org/obo/MONDO_0004253) (intraductal breast papillomatosis), [MONDO:0004250](http://purl.obolibrary.org/obo/MONDO_0004250) (extrahepatic bile duct papillary adenoma), [MONDO:0002194](http://purl.obolibrary.org/obo/MONDO_0002194) (vestibular papilloma), [MONDO:0004827](http://purl.obolibrary.org/obo/MONDO_0004827) (esophagus squamous cell papilloma), [MONDO:0002765](http://purl.obolibrary.org/obo/MONDO_0002765) (plantar verrucous skin carcinoma), [MONDO:0002368](http://purl.obolibrary.org/obo/MONDO_0002368) (papillary serous cystadenocarcinoma), [MONDO:0003611](http://purl.obolibrary.org/obo/MONDO_0003611) (uterine ligament papillary cystadenoma associated with von hippel-lindau disease), [MONDO:0004788](http://purl.obolibrary.org/obo/MONDO_0004788) (cervix squamous papilloma), [MONDO:0002766](http://purl.obolibrary.org/obo/MONDO_0002766) (larynx verrucous carcinoma), [MONDO:0004148](http://purl.obolibrary.org/obo/MONDO_0004148) (gallbladder papillary carcinoma), [MONDO:0003455](http://purl.obolibrary.org/obo/MONDO_0003455) (bile duct papillary neoplasm), [MONDO:0002761](http://purl.obolibrary.org/obo/MONDO_0002761) (cervical verrucous carcinoma), [MONDO:0003697](http://purl.obolibrary.org/obo/MONDO_0003697) (non-invasive verrucous carcinoma of the penis), [MONDO:0004787](http://purl.obolibrary.org/obo/MONDO_0004787) (cervical mullerian papilloma), [MONDO:0003698](http://purl.obolibrary.org/obo/MONDO_0003698) (penis verrucous carcinoma), [MONDO:0004267](http://purl.obolibrary.org/obo/MONDO_0004267) (squamous papillomatosis), [MONDO:0002763](http://purl.obolibrary.org/obo/MONDO_0002763) (urethral verrucous carcinoma), [MONDO:0004421](http://purl.obolibrary.org/obo/MONDO_0004421) (sclerosing breast papilloma), [MONDO:0002762](http://purl.obolibrary.org/obo/MONDO_0002762) (esophagus verrucous carcinoma), [MONDO:0006049](http://purl.obolibrary.org/obo/MONDO_0006049) (papillary lung adenocarcinoma), [MONDO:0004384](http://purl.obolibrary.org/obo/MONDO_0004384) (maxillary sinus inverted papilloma), [MONDO:0002363](http://purl.obolibrary.org/obo/MONDO_0002363) (papilloma), [MONDO:0002362](http://purl.obolibrary.org/obo/MONDO_0002362) (serous surface papilloma), [MONDO:0005074](http://purl.obolibrary.org/obo/MONDO_0005074) (papillary cystadenocarcinoma), [MONDO:0021538](http://purl.obolibrary.org/obo/MONDO_0021538) (verrucous carcinoma of oral cavity), [MONDO:0003829](http://purl.obolibrary.org/obo/MONDO_0003829) (chromophil adenoma of the kidney), [MONDO:0002979](http://purl.obolibrary.org/obo/MONDO_0002979) (papillary squamous carcinoma), [MONDO:0003822](http://purl.obolibrary.org/obo/MONDO_0003822) (non-invasive bladder papillary urothelial neoplasm), [MONDO:0003789](http://purl.obolibrary.org/obo/MONDO_0003789) (hereditary papillary renal cell carcinoma), [MONDO:0005605](http://purl.obolibrary.org/obo/MONDO_0005605) (transitional cell papilloma), [MONDO:0021098](http://purl.obolibrary.org/obo/MONDO_0021098) (papillomatosis), [MONDO:0004353](http://purl.obolibrary.org/obo/MONDO_0004353) (extrahepatic biliary papillomatosis), [MONDO:0021097](http://purl.obolibrary.org/obo/MONDO_0021097) (intraductal breast papilloma), [MONDO:0021099](http://purl.obolibrary.org/obo/MONDO_0021099) (intraductal papillomatosis), [MONDO:0021091](http://purl.obolibrary.org/obo/MONDO_0021091) (papillary cystadenoma), [MONDO:0001779](http://purl.obolibrary.org/obo/MONDO_0001779) (vaginal squamous papilloma), [MONDO:0003716](http://purl.obolibrary.org/obo/MONDO_0003716) (kidney pelvis papillary carcinoma), [MONDO:0003717](http://purl.obolibrary.org/obo/MONDO_0003717) (renal pelvis papillary tumor), [MONDO:0003955](http://purl.obolibrary.org/obo/MONDO_0003955) (juvenile breast papillomatosis), [MONDO:0003831](http://purl.obolibrary.org/obo/MONDO_0003831) (type 2 papillary adenoma of the kidney), [MONDO:0002221](http://purl.obolibrary.org/obo/MONDO_0002221) (urethral urothelial papilloma), [MONDO:0003830](http://purl.obolibrary.org/obo/MONDO_0003830) (type 1 papillary adenoma of the kidney), [MONDO:0006149](http://purl.obolibrary.org/obo/MONDO_0006149) (clear cell papillary cystadenoma), [MONDO:0002063](http://purl.obolibrary.org/obo/MONDO_0002063) (breast papillomatosis), [MONDO:0002060](http://purl.obolibrary.org/obo/MONDO_0002060) (intraductal papilloma), 

**Mapped go classes:** [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0007093](http://purl.obolibrary.org/obo/GO_0007093) (mitotic cell cycle checkpoint), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0021953](http://purl.obolibrary.org/obo/GO_0021953) (central nervous system neuron differentiation), [GO:0048754](http://purl.obolibrary.org/obo/GO_0048754) (branching morphogenesis of an epithelial tube), [GO:1900407](http://purl.obolibrary.org/obo/GO_1900407) (regulation of cellular response to oxidative stress), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0031116](http://purl.obolibrary.org/obo/GO_0031116) (positive regulation of microtubule polymerization), [GO:0036126](http://purl.obolibrary.org/obo/GO_0036126) (sperm flagellum), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0060079](http://purl.obolibrary.org/obo/GO_0060079) (excitatory postsynaptic potential), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0060076](http://purl.obolibrary.org/obo/GO_0060076) (excitatory synapse), [GO:0007268](http://purl.obolibrary.org/obo/GO_0007268) (chemical synaptic transmission), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0010828](http://purl.obolibrary.org/obo/GO_0010828) (positive regulation of glucose transport), [GO:0048012](http://purl.obolibrary.org/obo/GO_0048012) (hepatocyte growth factor receptor signaling pathway), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0051497](http://purl.obolibrary.org/obo/GO_0051497) (negative regulation of stress fiber assembly), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0032675](http://purl.obolibrary.org/obo/GO_0032675) (regulation of interleukin-6 production), [GO:0014902](http://purl.obolibrary.org/obo/GO_0014902) (myotube differentiation), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0071526](http://purl.obolibrary.org/obo/GO_0071526) (semaphorin-plexin signaling pathway), [GO:0035024](http://purl.obolibrary.org/obo/GO_0035024) (negative regulation of Rho protein signal transduction), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0060665](http://purl.obolibrary.org/obo/GO_0060665) (regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0009925](http://purl.obolibrary.org/obo/GO_0009925) (basal plasma membrane), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0072593](http://purl.obolibrary.org/obo/GO_0072593) (reactive oxygen species metabolic process), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010801](http://purl.obolibrary.org/obo/GO_0010801) (negative regulation of peptidyl-threonine phosphorylation), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0017154](http://purl.obolibrary.org/obo/GO_0017154) (semaphorin receptor activity), [GO:0010800](http://purl.obolibrary.org/obo/GO_0010800) (positive regulation of peptidyl-threonine phosphorylation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0050918](http://purl.obolibrary.org/obo/GO_0050918) (positive chemotaxis), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0060048](http://purl.obolibrary.org/obo/GO_0060048) (cardiac muscle contraction), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010976](http://purl.obolibrary.org/obo/GO_0010976) (positive regulation of neuron projection development), [GO:0014812](http://purl.obolibrary.org/obo/GO_0014812) (muscle cell migration), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:1900745](http://purl.obolibrary.org/obo/GO_1900745) (positive regulation of p38MAPK cascade), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0051450](http://purl.obolibrary.org/obo/GO_0051450) (myoblast proliferation), [GO:0055013](http://purl.obolibrary.org/obo/GO_0055013) (cardiac muscle cell development), [GO:0050804](http://purl.obolibrary.org/obo/GO_0050804) (modulation of chemical synaptic transmission), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0005008](http://purl.obolibrary.org/obo/GO_0005008) (hepatocyte growth factor-activated receptor activity), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:2001028](http://purl.obolibrary.org/obo/GO_2001028) (positive regulation of endothelial cell chemotaxis), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0050775](http://purl.obolibrary.org/obo/GO_0050775) (positive regulation of dendrite morphogenesis), [GO:0071635](http://purl.obolibrary.org/obo/GO_0071635) (negative regulation of transforming growth factor beta production), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:1905098](http://purl.obolibrary.org/obo/GO_1905098) (negative regulation of guanyl-nucleotide exchange factor activity), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:1901299](http://purl.obolibrary.org/obo/GO_1901299) (negative regulation of hydrogen peroxide-mediated programmed cell death), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0070495](http://purl.obolibrary.org/obo/GO_0070495) (negative regulation of thrombin-activated receptor signaling pathway), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- Thing 54.34%
- [GO:0097722](http://purl.obolibrary.org/obo/GO_0097722) (sperm motility) 51.09%
- [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia) 51.09%
- [GO:0060665](http://purl.obolibrary.org/obo/GO_0060665) (regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling) 51.09%
- [GO:0060638](http://purl.obolibrary.org/obo/GO_0060638) (mesenchymal-epithelial cell signaling) 51.09%
- [GO:0044783](http://purl.obolibrary.org/obo/GO_0044783) (G1 DNA damage checkpoint) 51.09%
- [GO:0042772](http://purl.obolibrary.org/obo/GO_0042772) (DNA damage response, signal transduction resulting in transcription) 51.09%
- [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator) 51.09%
- [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint) 51.09%
- [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility) 51.09%
- [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage) 51.09%
- [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator) 51.09%
- [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia) 51.09%
- [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint) and [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle) 51.09%
- [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint) and [GO:2000045](http://purl.obolibrary.org/obo/GO_2000045) (regulation of G1/S transition of mitotic cell cycle) 51.09%


